| # | Drug | Count |
|---|---|---|
| 0 | GABAPENTIN | 14 |
| 1 | OMEPRAZOLE | 13 |
| 2 | OMEPRAZOLE MAGNESIUM | 13 |
| 3 | BENZTROPINE | 12 |
| 4 | FLUOXETINE HYDROCHLORIDE | 12 |
| 5 | FLUOXETINE | 10 |
| 6 | METHOTREXATE SODIUM | 10 |
| 7 | METHOTREXATE | 9 |
| 8 | CLOBAZAM | 7 |
| 9 | MERCAPTOPURINE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GABA (GAMMA-AMINOBUTYRIC ACID) | 1 | 0.0047 |
| 1 | PURIXAN | 3 | 0.0039 |
| 2 | SODIUM PHENYLBUTYRATE | 1 | 0.0024 |
| 3 | GLYCEROL PHENYLBUTYRATE | 3 | 0.0022 |
| 4 | BENZTROPINE | 12 | 0.0016 |
| 5 | GLYCOPYRRONIUM | 1 | 0.0006 |
| 6 | DROPERIDOL | 1 | 0.0006 |
| 7 | PERPHENAZINE | 1 | 0.0005 |
| 8 | RAMUCIRUMAB | 3 | 0.0005 |
| 9 | MERCAPTOPURINE | 7 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 13 |
| 1 | Corticosteroid [EPC] | 13 |
| 2 | Proton Pump Inhibitor [EPC] | 13 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 9 |
| 4 | Aminosalicylate [EPC] | 5 |
| 5 | Atypical Antipsychotic [EPC] | 5 |
| 6 | Antirheumatic Agent [EPC] | 4 |
| 7 | Mood Stabilizer [EPC] | 4 |
| 8 | Anti-epileptic Agent [EPC] | 3 |
| 9 | Azole Antifungal [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 3 | 0.0005 |
| 1 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 2 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 3 | Aminosalicylate [EPC] | 5 | 0.0000 |
| 4 | Typical Antipsychotic [EPC] | 1 | 0.0000 |
| 5 | Antirheumatic Agent [EPC] | 4 | 0.0000 |
| 6 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 8 | Phenothiazine [EPC] | 1 | 0.0000 |
| 9 | Glycopeptide Antibacterial [EPC] | 2 | 0.0000 |